Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02104427
Title PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors TaiGen Biotechnology Co., Ltd.
Indications

multiple myeloma

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

Burixafor

Filgrastim

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stony Brook University Hospital Stony Brook New York 11794 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field